Phase II Trial of Improved Regimen with Gemcitabine in Patients 
with Advanced Non-small Cell Lung Cancer

Phase II Trial of Improved Regimen with Gemcitabine in Patients 
with Advanced Non-small Cell Lung Cancer

Background and objective Gemcitabine-platinum-combined with chemotherapy is the most common treatment for advanced non-small cell lung cancer (NSCLC). Gemcitabine is administered once a week in a general three-week schedule. In the present study, gemcitabine is administered on d1 and d5 to improve c...

Full description

Bibliographic Details
Main Authors: Lulu MIAO, Yun FAN, Zhiyu HUANG, Nengming LIN, Lvhong LUO, Haifeng YU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Gemcitabine
Combined chemotherapy regimens
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.01

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.01

Similar Items